Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy
Takahiro Masuda(Jichi Medical University), Eiji Kusano(Edogawa Hospital), Yoshitaka Iwazu(Jichi Medical University), Takashi Murakami(Jichi Medical University), Takahisa Kobayashi, Nobuhiro Sasaki(Osaka Kaisei Hospital), Masami Shinohara, Mutsuko Nonaka‐Sarukawa, Genro Fujisawa(Fujisawa City Hospital), Yuko Watanabe(Jichi Medical University), Kazuyuki Shimada(Nagoya University), Mariko Kimura(Kobe Women's University), Shigeaki Muto(Jichi Medical University), Eiji Kobayashi(Oita University)
American Journal of Physiology-Heart and Circulatory Physiology
March 5, 2012
Cited by 32
Related Papers
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives
|Circulation|2003|1.2k
Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives
|Hypertension|2001|750
Nocturnal Fall of Blood Pressure and Silent Cerebrovascular Damage in Elderly Hypertensive Patients
|Hypertension|1996|620
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308